David Matly
President · Inhibrx Biosciences, Inc.
Individual
- 2026
- Apr 27, 2026
- 1
Filings (90d)
0
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Matly files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark Lappe - $3.64M in INBX purchases and sales in the last 12 months
- Jon Faiz Kayyem - $1.57M in INBX purchases and sales in the last 12 months
- Douglas Forsyth - $287K in INBX purchases and sales in the last 12 months
- Kimberly Manhard - $279K in INBX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Matly?
David Matly is a corporate insider, tracked as President of Inhibrx Biosciences, Inc. (INBX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did David Matly last file a Form 4?
The only primary Form 4 on record is dated 27 April 2026.